Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

Valeant Higher After Q2 Report

Courtesy of Benzinga.

Valeant Pharmaceuticals Intl Inc (NYSE: VRX) shares are trading higher by $1.40 (8.8 percent) at $16.77 in Tuesday’s session.

The Street is more than satisfied with its Q2 that revealed earnings of $1.05 per share on sales of $2.33 billion. The company reaffirmed its FY 2017 EBITDA guidance.

In a volatile session, Valeant was unable to hold its gains off the open, peaking at $16.97 before swooning to $16.08. That high coincides with a trio of highs under just under $17.00 from late July and early August.

Since making its intraday low, it has battled back to the upper $16.00 handle, but has yet to make a new high for the session.

Posted-In: Technicals Intraday Update Movers Trading Ideas


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!